These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6487473)

  • 1. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.
    Hibbard DM; Peters JR; Hunninghake DB
    Br J Clin Pharmacol; 1984 Sep; 18(3):337-42. PubMed ID: 6487473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide.
    Hunninghake DB; King S; LaCroix K
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):151-4. PubMed ID: 7076343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cholestyramine and colestipol on the absorption of phenytoin.
    Callaghan JT; Tsuru M; Holtzman JL; Hunninghake DB
    Eur J Clin Pharmacol; 1983; 24(5):675-8. PubMed ID: 6873150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cholestyramine and colestipol on the absorption of diclofenac in man.
    al-Balla SR; el-Sayed YM; al-Meshal MA; Gouda MW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):441-5. PubMed ID: 7981930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of colestipol and cholestyramine on the systemic clearance of intravenous ibuprofen in rabbits.
    el-Sayed YM; al-Meshal MA; al-Angary AA; Lutfi KM; Gouda MW
    J Pharm Pharmacol; 1994 Jan; 46(1):73-5. PubMed ID: 8201531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of colestipol hydrochloride on drug absorption in the rat II.
    Phillips WA; Ratchford JM; Schultz JR
    J Pharm Sci; 1976 Sep; 65(9):1285-91. PubMed ID: 966139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of colestipol and cholestyramine on ibuprofen bioavailability in man.
    al-Meshal MA; el-Sayed YM; al-Balla SR; Gouda MW
    Biopharm Drug Dispos; 1994 Aug; 15(6):463-71. PubMed ID: 7993984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.
    Neuvonen PJ; Kivistö K; Hirvisalo EL
    Br J Clin Pharmacol; 1988 Feb; 25(2):229-33. PubMed ID: 3358884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and efficacy of colestipol hydrochloride for accelerated elimination of teriflunomide.
    Robertson D; Dixon C; Aungst A; McCoy B; Moreo N; Casady L; Maldonado J
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1403-1407. PubMed ID: 29064296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of colestipol hydrochloride on the bioavailability and pharmacokinetics of clofibrate.
    DeSante KA; DiSanto AR; Albert KS; Weber DJ; Welch RD; Vecchio TJ
    J Clin Pharmacol; 1979; 19(11-12):721-5. PubMed ID: 536468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of cholestyramine or colestipol combinations with six vehicles.
    Shaefer MS; Jungnickel PW; Jacobs EW; Maloley PA
    Clin Pharm; 1987 Jan; 6(1):51-4. PubMed ID: 3816107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
    Ryan JR; Jain A
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):268-73. PubMed ID: 4557535
    [No Abstract]   [Full Text] [Related]  

  • 16. Apparent reduced absorption of gemfibrozil when given with colestipol.
    Forland SC; Feng Y; Cutler RE
    J Clin Pharmacol; 1990 Jan; 30(1):29-32. PubMed ID: 2303577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
    Wong L; Nation RL; Chiou WL; Mehta PK
    Br J Clin Pharmacol; 1979 Aug; 8(2):163-7. PubMed ID: 486291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
    LaRosa J
    Cardiology; 1989; 76 Suppl 1():55-61; discussion 61-4. PubMed ID: 2653624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.
    Von Bahr C; Hermansson J; Tawara K
    Br J Clin Pharmacol; 1982 Jul; 14(1):79-82. PubMed ID: 7104170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulations.
    Turner SW; Jungbluth GL; Knuth DW
    Biopharm Drug Dispos; 2002 Dec; 23(9):369-77. PubMed ID: 12469330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.